The Resource Local drug delivery for coronary artery disease, [edited by] Edoardo Camenzind, Ivan K. de Scheerder

Local drug delivery for coronary artery disease, [edited by] Edoardo Camenzind, Ivan K. de Scheerder

Label
Local drug delivery for coronary artery disease
Title
Local drug delivery for coronary artery disease
Statement of responsibility
[edited by] Edoardo Camenzind, Ivan K. de Scheerder
Contributor
Subject
Genre
Language
eng
Summary
Pioneers in the field, the editors of "Local Drug Delivery for Coronary Artery Disease" have assembled an excellent team of contributors with extensive experience of threatened vessel closure and restenosis, acute thrombosis, hyper-proliferative cellular
Cataloging source
N$T
Dewey number
  • 615.6
  • 616.123061
Illustrations
illustrations
Index
index present
LC call number
RS199.5
LC item number
.L63 2005eb
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
Label
Local drug delivery for coronary artery disease, [edited by] Edoardo Camenzind, Ivan K. de Scheerder
Publication
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
http://library.link/vocab/branchCode
  • net
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • ""Book Cover""; ""Title""; ""Copyright""; ""Contents""; ""List of contributors""; ""Preface""; ""1. The purpose of site-specific therapy""; ""2. Local drug delivery: impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall""; ""3. Catheter-based and stent-based treatment for coronary artery disease""; ""4. The ClearWayâ?{u00A2} microporous balloon catheter""; ""5. The Dispatch® coronary infusion catheter""; ""6. The Remedyâ?{u00A2} PTCA dilatation infusion cather""; ""7. The Infiltratorâ?{u00A2} angioplasty balloon cather""
  • ""20. Direct antithrombins""""21. Tissue factor inhibitors""; ""22. Nitric oxide-related interventions and restenosis""; ""23. Vitamin E and its multiple properties: anti, pro, and non-oxidative activities""; ""24. The dexamethasone eluting stent""; ""25. Antiinflammatory approaches to restenosis""; ""26. The role of matrix metalloproteinase inhibitors after arterial injury""; ""27. Methotrexate: a potential drug for stent-mediated local drug delivery: antiinflammatory and antiproliferative characteristics""
  • ""28. Actin-skeleton inhibitors: potential candidates for local drug delivery in the prevention of in-stent restenosis?""""29. Local delivery of antisense oligomers to c-myc for the prevention of restenosis""; ""30. Site-specific delivery of cytostatic agents""; ""31. Catheter-based delivery of NOS gene""; ""32. Carbon-coated stents: diamond-like stent coatings""; ""33. Long-term biocompatibility evaluation of poly-bis-trifluorethoxyphosphazene (PTFEP): a novel biodegradable polymer stent coating in a porcine coronary stent model""
  • ""34. Biocompatibility evaluation of biosoluble stent coatings in a porcine coronary stent model""""35. Glycoprotein (GP) GIIb/IIIa receptor antagonist eluting stents""; ""36. Activated protein C eluting stents""; ""37. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine (PC)-coated drug delivery stents reduces inflammation and neointimal hyperplasia in a porcine coronary stent model""; ""38. Methotrexate loaded BOBSC-coated coronary stents reduce neointimal hyperplasia in a porcine coronary model""; ""39. Rapamycin eluting stents""
  • ""8. The Infiltratorâ?{u00A2} local drug delivery cather""""9. The needle catheter""; ""10. Stent-mediated local drug delivery""; ""11. Silicon carbide-coated stents""; ""12. The Carbostent: a Carbofilmâ?{u00A2}-coatedstent""; ""13. The PC-coated BiodivYsioâ?{u00A2} stent""; ""14. PTFE-covered stents""; ""15. Overview of drug delivery coatings""; ""16. Phosphorylcholine (PC Technologyâ?{u00A2}) coated stents as a drug delivery platform""; ""17. Direct stent coating: an alternative for polymers?""; ""18. Radioactive stents""; ""19. Overview of potential drugs to inhibit in-stent restenosis""
Control code
ocm63896479
Dimensions
unknown
Extent
1 online resource (xiii, 594 pages)
File format
unknown
Form of item
online
Isbn
9780203640388
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
illustrations (some color)
Quality assurance targets
not applicable
http://library.link/vocab/recordID
.b24470752
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
  • (OCoLC)63896479
  • pebco0203640381

Library Locations

    • Deakin University Library - Geelong Waurn Ponds CampusBorrow it
      75 Pigdons Road, Waurn Ponds, Victoria, 3216, AU
      -38.195656 144.304955
Processing Feedback ...